<!DOCTYPE html>
<html>
  <head>
    <title>Melanoma</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/dermatology/">dermatology</a></li>
      <li class="active">Melanoma</li>
  </ol>

  <div class="page-header">
 
    <h1>Melanoma</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Melanoma</strong></a>
          <div class="toc">
<ul>
<li><a href="#maoripacific">Maori/Pacific</a></li>
<li><a href="#melanocytic-naevus">Melanocytic naevus</a></li>
<li><a href="#atypical-naevusclarks-naevus">Atypical naevus/Clark’s naevus</a></li>
<li><a href="#risk-factors-for-melanoma">Risk factors for melanoma:</a></li>
<li><a href="#types-of-melanoma">Types of melanoma</a></li>
<li><a href="#toenailssubungla-melanoma">Toenails/subungla melanoma</a></li>
<li><a href="#abcde-checklist">ABCDE checklist</a></li>
<li><a href="#glasgow-seven-point-checklist">Glasgow seven point checklist</a></li>
<li><a href="#mole-mapping">Mole mapping</a></li>
<li><a href="#feet">Feet</a></li>
<li><a href="#excision">Excision:</a></li>
<li><a href="#clarks-level">CLark’s Level</a></li>
<li><a href="#breslow-thickness">Breslow thickness</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>NZ has one of highest rates of melanoma in teh world</p>
<p>most common cancer NZ men 25-44yo</p>
<p>11% of all cancer registrations</p>
<p>tenth most common cause of death from cancer</p>
<p>mortality invasive melanoma = 15%</p>
<p>males > females</p>
<p>mortality 90% higher cf. females</p>
<p>Melanoma = type of skin cnacner that develops from melanocytes</p>
<ul>
<li>
<p>normally located in basal layer of epidermis or whitin dermis</p>
</li>
<li>
<p>may develop wihin existing melanocytic naevus</p>
</li>
<li>
<p>more often arises in normal skin</p>
</li>
</ul>
</blockquote>
<h3 id="maoripacific">Maori/Pacific</h3>
<ul>
<li>
<p>signifiantly less common</p>
</li>
<li>
<p>2.7/100 000 people /year</p>
</li>
<li>
<p>present with thicker lesions</p>
</li>
</ul>
<h3 id="melanocytic-naevus">Melanocytic naevus</h3>
<ul>
<li>
<p>benign proliferation of melanocytes</p>
</li>
<li>
<p>Most euro NZers have 20-50 moles</p>
</li>
<li>
<p>congential/acquired</p>
</li>
<li>
<p>Development of new mole >50yo less common</p>
</li>
</ul>
<h3 id="atypical-naevusclarks-naevus">Atypical naevus/Clark’s naevus</h3>
<ul>
<li>
<p>melanocytic naevus</p>
<ul>
<li>unusual in appearacne</li>
</ul>
</li>
<li>
<p>Most develop during childhood</p>
</li>
<li>
<p>>5 = higher risk of melanoma</p>
</li>
<li>
<p>atypical = </p>
<ul>
<li>
<p>size >5-6mm</p>
</li>
<li>
<p>Border htat is blurry or ill-defined</p>
</li>
<li>
<p>unusual irregular shape</p>
</li>
<li>
<p>variation in colour</p>
</li>
<li>
<p>variation in profile i.e. flat and rasied parts</p>
</li>
</ul>
</li>
</ul>
<h3 id="risk-factors-for-melanoma">Risk factors for melanoma:</h3>
<ul>
<li>
<p>Age:</p>
<ul>
<li>
<p>>60yo</p>
</li>
<li>
<p>older men - thicker lesions</p>
</li>
<li>
<p>1-2% in children - thicker lesions</p>
</li>
</ul>
</li>
<li>
<p>Past history of skin cancer (inc. non-melanoma)</p>
<ul>
<li>
<p>melanoma = 10x increase developing another melanoma</p>
</li>
<li>
<p>non melanoma  = 4x</p>
</li>
</ul>
</li>
<li>
<p>Family history o fmelanoma</p>
<ul>
<li>
<p>first degree = 2x</p>
</li>
<li>
<p>10% of people with melanoma have family hisotry of melanoma in first degree relative</p>
</li>
</ul>
</li>
<li>
<p>Number of moles</p>
<ul>
<li>number of melanocytic naevi increases: esp if >100</li>
</ul>
</li>
<li>
<p>Type of mole</p>
<ul>
<li>
<p>atypical naevi</p>
<ul>
<li>6x inc if >5</li>
</ul>
</li>
</ul>
</li>
<li>
<p>UV radiation</p>
<ul>
<li>UVB/UVA or UVA from sunbed</li>
</ul>
</li>
<li>
<p>Skin type</p>
</li>
<li>
<p>Changeable weather:</p>
<ul>
<li>intermittent cf. constant: sunseeking behaviour</li>
</ul>
</li>
</ul>
<h3 id="types-of-melanoma">Types of melanoma</h3>
<ul>
<li>
<p>10% are non-pigmented</p>
</li>
<li>
<p>Superficial spreading melanoma</p>
</li>
<li>
<p>most common</p>
</li>
<li>
<p>sun exposed parts of body</p>
</li>
<li>
<p>flat patch that is irregularly shaped</p>
</li>
<li>
<p>irregularly pigmented</p>
</li>
<li>
<p>irregular outline</p>
</li>
<li>
<p>porlonged pre-invasive in-situ phase</p>
</li>
<li>
<p>Nodular melanoma</p>
</li>
<li>
<p>2nd most common type</p>
</li>
<li>
<p>rapidly growing</p>
<ul>
<li>over several wekes to months</li>
</ul>
</li>
<li>
<p>pink, red, brown or black nodule</p>
</li>
<li>
<p>pigmentation more uniform cf. SSM</p>
</li>
<li>
<p>may arise within existing melanocytic naevus or in normal appearing skin</p>
</li>
<li>
<p>more likely to bleed/ulcerate</p>
</li>
<li>
<p>doesn’t have in-situ phase</p>
</li>
<li>
<p>EFG(elevated, firm and growing)</p>
</li>
<li>
<p>Lentigo maligna melanoma</p>
</li>
<li>
<p>sundamaged skin in older people</p>
</li>
<li>
<p>long pre-invasive insitu stage - years to decades</p>
</li>
<li>
<p>enlarging irregularly pigmented freckle</p>
</li>
<li>
<p>Acra lentiginous melanoma</p>
</li>
<li>
<p>palms, soles, underneath finger/toe nails</p>
</li>
<li>
<p>5% melanomas</p>
</li>
<li>
<p>most common in dark-skinned</p>
</li>
<li>
<p>may not demonstrate characteristic associetated with melanoma at other body sites</p>
</li>
<li>
<p>Mucosal lentiginous melanoma</p>
</li>
<li>
<p>arise from mucosal or paramucosal sites</p>
<ul>
<li>vulva, vagina, anus, penis, eyelids, conjunctiva, oral cavity, lips</li>
</ul>
</li>
</ul>
<h3 id="toenailssubungla-melanoma">Toenails/subungla melanoma</h3>
<ul>
<li>
<p>longitudinal melanoychia (brown/black stripe throughout full length of nail)</p>
</li>
<li>
<p>skin surrounding nail folds may be involved</p>
</li>
<li>
<p>most comon = subungal haematoma</p>
</li>
<li></li>
</ul>
<h3 id="abcde-checklist">ABCDE checklist</h3>
<ul>
<li>
<p>Asymmetry</p>
</li>
<li>
<p>Border irregularilty</p>
<ul>
<li>
<p>notched</p>
</li>
<li>
<p>blurred</p>
</li>
<li>
<p>ragged edges</p>
</li>
</ul>
</li>
<li>
<p>Colour variegation</p>
<ul>
<li>
<p>different colours </p>
<ul>
<li>brown,black,white,red,blue</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Dianmeter >6mm</p>
</li>
<li>
<p>Evolution or enlargement</p>
</li>
<li>
<p>not very specific</p>
</li>
</ul>
<h3 id="glasgow-seven-point-checklist">Glasgow seven point checklist</h3>
<ul>
<li>
<p>Major (2 points)</p>
<ul>
<li>
<p>change in size</p>
</li>
<li>
<p>change in shape</p>
</li>
<li>
<p>change in colour</p>
</li>
</ul>
</li>
<li>
<p>Minor (1 point)</p>
<ul>
<li>
<p>inflammation</p>
</li>
<li>
<p>crusting, oozing, bleeding</p>
</li>
<li>
<p>sensory change/itch</p>
</li>
<li>
<p>Lesion diameter >= 6mm</p>
</li>
</ul>
</li>
<li>
<p>excision if >3 points or more</p>
</li>
</ul>
<h3 id="mole-mapping">Mole mapping</h3>
<ul>
<li>
<p>Mole mapping most useful in patients with a large number of moles, atypical naevi, oles on back that are hard to see and those at high risk ok melanoma</p>
</li>
<li>
<p>advantages:</p>
<ul>
<li>
<p>rapid </p>
</li>
<li>
<p>lesions of concern are detected early - allowing careful follow-up</p>
</li>
<li>
<p>unnecessary excisions may be reduced</p>
</li>
<li>
<p>access to mole mapping quicker/easier than access to dermatologist</p>
</li>
</ul>
</li>
<li>
<p>disadvantages</p>
<ul>
<li>
<p>scalp/genitals may be missed</p>
</li>
<li>
<p>false negatives</p>
</li>
<li>
<p>false positives</p>
</li>
<li>
<p>interval b/w molemapping appt may be too long for rapidly growing lesions</p>
</li>
<li>
<p>Cost (\~300$)</p>
</li>
</ul>
</li>
</ul>
<h3 id="feet">Feet</h3>
<ul>
<li>
<p>CUBED acronym</p>
<ul>
<li>
<p>coloured lesions where any part is not skin coloured</p>
</li>
<li>
<p>uncertain diagnosis</p>
</li>
<li>
<p>bleedinglesions on foot or under nail</p>
<ul>
<li>including chronic granulation tissue</li>
</ul>
</li>
<li>
<p>Enlargement or deterioration of lesion or ulcer despite treatmnet</p>
</li>
<li>
<p>Delay in healing (>2months)</p>
</li>
</ul>
</li>
<li>
<p>difficult to determine cuase of subungual bleeding</p>
</li>
</ul>
<h3 id="excision">Excision:</h3>
<p>in situ (pTis) : 5mm margin</p>
<p>pT1 \&lt;1mm: 1cm</p>
<p>>1mm = refer</p>
<p>pT2-pT3 1-4mm: 1-2cm</p>
<p>pT4 >4mm: 2cm</p>
<p>sentinal node biopsy discuss with patients who have a primary tumour 1.2-3.5mm thick</p>
<p>genetic testing not worthwhile</p>
<h3 id="clarks-level">CLark’s Level</h3>
<ol>
<li>
<p>Melanoma confiend to epidermis</p>
</li>
<li>
<p>Invasion into papillary dermis</p>
</li>
<li>
<p>Invasion to junction of papillary and reticular dermis</p>
</li>
<li>
<p>Invasion into reticular dermis</p>
</li>
<li>
<p>Invasion into subcutaneous fat</p>
</li>
</ol>
<h3 id="breslow-thickness">Breslow thickness</h3>
<ul>
<li>
<p>measurement in mm thickness of melanoma = depth of penetration</p>
</li>
<li>
<p>\&lt;1mm lower risk</p>
</li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
